149 related articles for article (PubMed ID: 37716904)
21. Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids.
Lam T; Hayman J; Berecki-Gisolf J; Sanfilippo P; Lubman DI; Nielsen S
Addiction; 2022 Mar; 117(3):623-636. PubMed ID: 34338377
[TBL] [Abstract][Full Text] [Related]
22. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
[TBL] [Abstract][Full Text] [Related]
23. A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions.
Pourmand A; Beisenova K; Shukur N; Tebo C; Mortimer N; Mazer-Amirshahi M
Am J Emerg Med; 2021 Oct; 48():316-322. PubMed ID: 34274576
[TBL] [Abstract][Full Text] [Related]
24. Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.
Saloner B; Whitley P; LaRue L; Dawson E; Huskey A
JAMA Netw Open; 2021 Sep; 4(9):e2123019. PubMed ID: 34505888
[TBL] [Abstract][Full Text] [Related]
25. Opioid Overdose Outbreak - West Virginia, August 2016.
Massey J; Kilkenny M; Batdorf S; Sanders SK; Ellison D; Halpin J; Gladden RM; Bixler D; Haddy L; Gupta R
MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):975-980. PubMed ID: 28934186
[TBL] [Abstract][Full Text] [Related]
26. Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence.
Wakeman SE; Chang Y; Regan S; Yu L; Flood J; Metlay J; Rigotti N
J Addict Med; 2019; 13(4):253-257. PubMed ID: 30550392
[TBL] [Abstract][Full Text] [Related]
27. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco.
Carter J; Zevin B; Lum PJ
Addict Sci Clin Pract; 2019 May; 14(1):20. PubMed ID: 31060600
[TBL] [Abstract][Full Text] [Related]
28. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
[TBL] [Abstract][Full Text] [Related]
29. Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.
Daniulaityte R; Nahhas RW; Silverstein S; Martins S; Carlson RG
J Subst Use Addict Treat; 2023 Apr; 147():208973. PubMed ID: 36804351
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapy of Opioid Use Disorder-Update and Current Challenges.
Racha S; Buresh M; Fingerhood M
Psychiatr Clin North Am; 2022 Sep; 45(3):335-346. PubMed ID: 36055727
[TBL] [Abstract][Full Text] [Related]
31. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
[TBL] [Abstract][Full Text] [Related]
32. Polysubstance Use in Adults With Opioid Use Disorder Receiving Buprenorphine Maintenance.
Elarabi HF; Radwan DN; Adem A; Marsden J; Lee AJ
J Addict Med; 2023 Jan-Feb 01; 17(1):74-78. PubMed ID: 35793664
[TBL] [Abstract][Full Text] [Related]
33. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
34. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
[TBL] [Abstract][Full Text] [Related]
35. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
[TBL] [Abstract][Full Text] [Related]
36. Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMA.
Bakouni H; Sharafi H; Drouin S; Fortin R; Marsan S; Brissette S; Socias ME; Le Foll B; Lim R; Jutras-Aswad D
Can J Psychiatry; 2024 Apr; 69(4):252-263. PubMed ID: 37899716
[TBL] [Abstract][Full Text] [Related]
37. Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder.
D'Onofrio G; Perrone J; Hawk KF; Cowan E; McCormack R; Coupet E; Owens PH; Martel SH; Huntley K; Walsh SL; Lofwall MR; Herring A;
Acad Emerg Med; 2023 Dec; 30(12):1264-1271. PubMed ID: 37501652
[TBL] [Abstract][Full Text] [Related]
38. Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.
Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA
Am J Emerg Med; 2021 Dec; 50():409-412. PubMed ID: 34481260
[TBL] [Abstract][Full Text] [Related]
39. Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July-December 2017 to January-June 2018.
Gladden RM; O'Donnell J; Mattson CL; Seth P
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(34):737-744. PubMed ID: 31465320
[TBL] [Abstract][Full Text] [Related]
40. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]